Weimin Fan
- Microbiology top 0.2%
- Antimicrobial Peptides and Activities 17
- Cancer Research top 2%
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 8
- Biomaterials top 2%
- Organic Chemistry top 2%
- Antimicrobial agents and applications 13
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
-
- Circular RNAs in diseases 13
- RNA modifications and cancer 4
-
- Estrogen and related hormone effects 7
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Weimin Fan
63 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Microbiology 975
- Cancer Research 767
- Biomaterials 549
- Organic Chemistry 1.0k
- Molecular Medicine 152
Countries citing papers authored by Weimin Fan
This map shows the geographic impact of Weimin Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Fan more than expected).
Fields of papers citing papers by Weimin Fan
This network shows the impact of papers produced by Weimin Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Fan. The network helps show where Weimin Fan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weimin Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2021 | 11 | |
| 3 | 2020 | 64 | |
| 4 | 2019 | 14 | |
| 5 | 2019 | 61 | |
| 6 | 2019 | 77 | |
| 7 | 2018 | 282 | |
| 8 | 2018 | 70 | |
| 9 | 2017 | 70 | |
| 10 | 2017 | 78 | |
| 11 | 2015 | 13 | |
| 12 | 2013 | 18 | |
| 13 | 2013 | 22 | |
| 14 | 2013 | 86 | |
| 15 | 2013 | 102 | |
| 16 | 2012 | 40 | |
| 17 | 2012 | 132 | |
| 18 | 2009 | 22 | |
| 19 | The culture of Vero cells and rabies virus by a domestic cell bioreactor | 1999 | 1 |
| 20 | 1991 | 13 |
About Weimin Fan
Weimin Fan is a scholar working on Microbiology, Cancer Research and Molecular Medicine, having authored 63 papers that have together received 3.5k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (17 papers), MicroRNA in disease regulation (17 papers), Antimicrobial agents and applications (13 papers), Circular RNAs in diseases (13 papers), Cancer-related molecular mechanisms research (8 papers), Estrogen and related hormone effects (7 papers), Antibiotic Resistance in Bacteria (6 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Microbiology (975 citations), Cancer Research (767 citations) and Biomaterials (549 citations). Weimin Fan has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Bisha Ding, Weiyang Lou, Kaijin Xu, Yi‐Yan Yang, Lanjuan Li, Yi Yan Yang, Liang Xu, Huaying Wang, Lihong Liu and Chang Bao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.